ZAC Cognitive Explainable-AI for Situational Awareness recognized as far superior algorithm to achieve Self-Driving Level-5 than Neural Nets

Z Advanced Computing, Inc. (ZAC), the pioneer Cognitive Explainable-AI (Artificial Intelligence) (Cognitive XAIor CXAI) software startup, has been recognized as far superior to the current algorithms (e.g., Neural Net, Deep Learning, Deep CNN, ResNet) to achieve Level-5 Self-Driving in future by Auto Connected Car (“Autonomous & Self-Driving Vehicle News”, Lynn Walford, Aug-17-2025) and by Investors […]

Caledonia approves quarterly dividend

Caledonia approves quarterly dividend GlobeNewswire November 10, 2025 ST HELIER, Jersey, Nov. 10, 2025 (GLOBE NEWSWIRE) — As announced in the third quarter results this morning, Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) has approved a quarterly dividend of 14 United States cents (US$0.14) on each of

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

(NASDAQ:JSPR), ATLANTA, Nov. 10, 2025 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information regarding Jasper's business, operations, and compliance policies, including allegations that: (i)

Glaucoma 360 2026: Where Science, Innovation, and Collaboration Shape the Future of Vision

SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Glaucoma Research Foundation (GRF) today announced the 15th annual Glaucoma 360 event, which unites research, industry, and philanthropy to prevent vision loss and speed the cure for glaucoma. The 2026 Glaucoma 360 event will be held January 29 to 31, at the Westin St. Francis San Francisco

Glaucoma 360 2026: Where Science, Innovation, and Collaboration Shape the Future of Vision

Glaucoma 360 2026: Where Science, Innovation, and Collaboration Shape the Future of Vision Annual event accelerates progress toward curing glaucoma, from groundbreaking research to emerging therapies GlobeNewswire November 10, 2025 SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Glaucoma Research Foundation (GRF) today announced the 15th annual Glaucoma 360 event, which unites research, industry, and

WineDirect Fulfillment Celebrates Strategic Partnership with Jackson Family Wines

WineDirect Fulfillment is proud to highlight its long-standing and evolving partnership withJackson Family Wines, a collaboration built on shared values, innovation, and a commitment to excellence. https://mma.prnewswire.com/media/2817543/WDF_webRGB_Logo.jpg WineDirect Fulfillment Celebrates Strategic Partnership with Jackson Family Wines AtWineDirect Fulfillment, partnership is the foundation of everything we do. We operate as an extension of our clients' organizations,

DISTINGUISHED CANCER RESEARCHER STUART S. MARTIN, PHD, NAMED CHAIR OF THE DEPARTMENT OF PHARMACOLOGY & PHYSIOLOGY AT UM SCHOOL OF MEDICINE

Stuart S. Martin, PhD, an internationally recognized breast cancer researcher, has been appointed Chair of the University of Maryland School of Medicine (UMSOM) Department of Pharmacology & Physiology, DeanMark T. Gladwin, MD, announced today. As the distinguished Drs. Angela and Harry Brodie Professor of Translational Cancer Research, Dr. Martin has served as Interim Chair of

DISTINGUISHED CANCER RESEARCHER STUART S. MARTIN, PHD, NAMED CHAIR OF THE DEPARTMENT OF PHARMACOLOGY & PHYSIOLOGY AT UM SCHOOL OF MEDICINE

Stuart S. Martin, PhD, an internationally recognized breast cancer researcher, has been appointed Chair of the University of Maryland School of Medicine (UMSOM) Department of Pharmacology & Physiology, DeanMark T. Gladwin, MD, announced today. As the distinguished Drs. Angela and Harry Brodie Professor of Translational Cancer Research, Dr. Martin has served as Interim Chair of

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Jasper Therapeutics, Inc. (JSPR) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm GlobeNewswire November 10, 2025 ATLANTA, Nov. 10, 2025 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Jasper Therapeutics, Inc. (“Jasper” or the “Company”)

Scroll to Top